LifeClean International（651）株式概要ライフクリーン・インターナショナルAB（publish）は、スウェーデン国内外で消毒製品の研究、製造、マーケティング、販売を行っている。 詳細651 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績0/6財務の健全性1/6配当金0/6リスク分析キャッシュランウェイが1年未満である 過去1年間で株主の希薄化は大幅に進んだ 過去5年間で収益は年間10.3%減少しました。 German市場と比較して、過去 3 か月間の株価の変動が非常に大きい+1 さらなるリスクすべてのリスクチェックを見る651 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.00578.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-52m71m2016201920222025202620282031Revenue SEK 70.5mEarnings SEK 6.6mAdvancedSet Fair ValueView all narrativesLifeClean International AB (publ) 競合他社Bio-GateSymbol: DB:BIG1Market cap: €7.2mBRAIN BiotechSymbol: XTRA:BNNMarket cap: €64.7mNabaltecSymbol: XTRA:NTGMarket cap: €99.9mH&R GmbH KGaASymbol: XTRA:2HRAMarket cap: €173.1m価格と性能株価の高値、安値、推移の概要LifeClean International過去の株価現在の株価SEK 0.00552週高値SEK 0.0652週安値SEK 0.0004ベータ1.911ヶ月の変化0%3ヶ月変化78.57%1年変化-66.67%3年間の変化-99.17%5年間の変化-99.29%IPOからの変化-99.51%最新ニュースNew Risk • May 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (€5.44m market cap, or US$6.31m).お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Swedenお知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. Swedenお知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. SwedenNew Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€18.1m market cap, or US$19.5m).Reported Earnings • Oct 25Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.最新情報をもっと見るRecent updatesNew Risk • May 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (€5.44m market cap, or US$6.31m).お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Swedenお知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. Swedenお知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. SwedenNew Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€18.1m market cap, or US$19.5m).Reported Earnings • Oct 25Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.New Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-kr8.1m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr40m). Currently unprofitable and not forecast to become profitable over next 2 years (kr10m net loss in 2 years). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€19.5m market cap, or US$21.6m).Breakeven Date Change • Sep 03No longer forecast to breakevenThe analyst covering LifeClean International no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of kr3.00m in 2026. New forecast suggests the company will make a loss of kr4.00m in 2026.Reported Earnings • Sep 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: kr21.0m (up 47% from 2Q 2023). Net loss: kr12.8m (loss widened 21% from 2Q 2023). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany.Reported Earnings • May 08First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: kr16.0m (up 17% from 1Q 2023). Net loss: kr15.0m (loss widened 95% from 1Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.New Risk • Apr 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr40m free cash flow). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Revenue is less than US$5m (kr53m revenue, or US$5.0m). Market cap is less than US$100m (€37.6m market cap, or US$40.9m).Reported Earnings • Feb 21Full year 2023 earnings released: kr0.94 loss per share (vs kr0.83 loss in FY 2022)Full year 2023 results: kr0.94 loss per share (further deteriorated from kr0.83 loss in FY 2022). Revenue: kr53.7m (up 14% from FY 2022). Net loss: kr44.2m (loss widened 23% from FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr10.4m (up 17% from 3Q 2022). Net loss: kr11.9m (loss widened 44% from 3Q 2022). Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany.Reported Earnings • Aug 31Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: kr14.5m (down 2.6% from 2Q 2022). Net loss: kr10.6m (loss widened 46% from 2Q 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.New Risk • Aug 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr5.0m net loss in 2 years). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr48m revenue, or US$4.5m). Market cap is less than US$100m (€30.0m market cap, or US$32.9m).Reported Earnings • Feb 18Full year 2022 earnings released: kr0.83 loss per share (vs kr0.83 loss in FY 2021)Full year 2022 results: kr0.83 loss per share (further deteriorated from kr0.83 loss in FY 2021). Revenue: kr48.3m (down 18% from FY 2021). Net loss: kr36.1m (loss widened 1.0% from FY 2021). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Nov 10LifeClean Develops Revolutionary Method for PFAS RemovalLifeClean International AB (publ) ("the Company") announces that the Company has developed an effective method for removing PFAS substances ("PFAS") from fire-fighting foam tanks.PFAS are environmentally and health-damaging substances previously used on a large scale as an ingredient in, e.g., fire-fighting foams. The phase-out of PFAS is ongoing and global, which opens up a significant market potential for the Company. Successful customer tests of LifeClean's method have already been conducted. The LifeClean group, under the leadership of Chairman and founder Ragnar Krefting, has researched, developed, and successfully tested a new method for PFAS removal from contaminated surfaces. The method is adapted for the best effect against PFAS and is part of a new assortment in LifeClean's product range. The new product assortment is based on the Company's patented chlorine dioxide formulation and also includes ingredients from the subsidiary Kempartner. Test results of the LifeClean method at Södertörn's firefighting association of five fire foam tanks have shown positive results where =99.97% of PFAS substances in the tanks have been detached according to an accredited third-party laboratory. In January 2023, the LifeClean-treated tanks would otherwise have been plugged and disposed of following current environmental and waste legislation. Now, this does not need to be done after decontaminating with the LifeClean method, which means a great economic saving of public funds. The same problem exists in the rest of the world, and the Company will, in a first step, process the Nordic market and, in a second step, the rest of the EU. An investigation is underway to see if it is possible to obtain regulatory exemptions for faster sales to countries where additional authorization is required. The company estimates that approx. 75,000 fire trucks in Europe are PFAS-contaminated and in need of decontamination. The estimated revenue per fire truck is approx. SEK 60,000 +/- 20,000, depending on tank size. PFAS are a group of chemicals with unique properties such as heat resistance and have, among other things, been an important ingredient in fire-fighting foams for firefighting at areas such as airports, ships, and defense facilities worldwide. PFAS are very resilient to degradation and are sometimes referred to as "forever chemicals". There is a high global consensus that PFAS should be phased out, even in fire-fighting foams where, among others, the carcinogenic and reproductively toxic substances PFOS and PFOA have been used.Reported Earnings • Nov 06Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr9.10m (down 21% from 3Q 2021). Net loss: kr8.31m (loss narrowed 1.3% from 3Q 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.Board Change • May 03No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Board member Jan Sjowall was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr0.78 loss per share (down from kr0.14 loss in FY 2020). Revenue: kr55.3m (up 69% from FY 2020). Net loss: kr32.8m (loss widened kr29.6m from FY 2020). Revenue missed analyst estimates by 52%.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved revenues, although losses increased and control over costs was weaker. Third quarter 2021 results: Revenue: kr12.1m (up 261% from 3Q 2020). Net loss: kr8.42m (loss widened 271% from 3Q 2020).Reported Earnings • Aug 20Second quarter 2021 earnings released: kr0.15 loss per share (vs kr0.76 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: kr18.9m (down 3.2% from 2Q 2020). Net loss: kr6.36m (down 215% from profit in 2Q 2020).Breakeven Date Change • Jul 27Forecast to breakeven in 2021The analyst covering LifeClean International expects the company to break even for the first time. New forecast suggests the company will make a profit of kr2.00m in 2021. Earnings growth of 101% is required to achieve expected profit on schedule.Reported Earnings • May 06First quarter 2021 earnings releasedThe company reported a mediocre first quarter result with weaker earnings and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: kr12.0m (up 88% from 1Q 2020). Net loss: kr6.99m (down kr7.35m from profit in 1Q 2020).Reported Earnings • Feb 21Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).Is New 90 Day High Low • Jan 28New 90-day low: €0.93The company is down 11% from its price of €1.05 on 30 October 2020. The German market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.株主還元651DE ChemicalsDE 市場7D733.3%-0.3%3.2%1Y-66.7%5.7%2.5%株主還元を見る業界別リターン: 651過去 1 年間で5.7 % の収益を上げたGerman Chemicals業界を下回りました。リターン対市場: 651は、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is 651's price volatile compared to industry and market?651 volatility651 Average Weekly Movement263.7%Chemicals Industry Average Movement6.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%安定した株価: 651の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 651の 週次ボラティリティ は、過去 1 年間で222%から264%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト201222Anders Lundstromwww.lifeclean.seライフクリーン・インターナショナルAB（publish）は、スウェーデン国内および国際的に消毒製品の研究、製造、マーケティング、販売を行っている。床、壁、設備、家具などの表面に対して、芽胞菌、真菌、バクテリア、バイオフィルム、ウイルスを殺菌する表面消毒剤を開発し、特許を取得している。同社はヨーロッパ、アラブ首長国連邦、サウジアラビア、韓国で製品を販売している。ライフクリーン・インターナショナルAB（publ）は2012年に設立され、スウェーデンのウッデバラに本社を置いている。もっと見るLifeClean International AB (publ) 基礎のまとめLifeClean International の収益と売上を時価総額と比較するとどうか。651 基礎統計学時価総額€5.44m収益（TTM）-€3.05m売上高(TTM)€5.03m1.1xP/Sレシオ-1.8xPER（株価収益率651 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計651 損益計算書（TTM）収益SEK 54.62m売上原価SEK 29.11m売上総利益SEK 25.51mその他の費用SEK 58.67m収益-SEK 33.16m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.032グロス・マージン46.71%純利益率-60.71%有利子負債／自己資本比率665.8%651 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 23:40終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋LifeClean International AB (publ) 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Mats HyttingeRedeye
New Risk • May 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (€5.44m market cap, or US$6.31m).
お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Sweden
お知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. Sweden
お知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. Sweden
New Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€18.1m market cap, or US$19.5m).
Reported Earnings • Oct 25Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.
New Risk • May 22New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (118% average daily change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (€5.44m market cap, or US$6.31m).
お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Sweden
お知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. Sweden
お知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. Sweden
New Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€18.1m market cap, or US$19.5m).
Reported Earnings • Oct 25Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.
New Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-kr8.1m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr40m). Currently unprofitable and not forecast to become profitable over next 2 years (kr10m net loss in 2 years). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€19.5m market cap, or US$21.6m).
Breakeven Date Change • Sep 03No longer forecast to breakevenThe analyst covering LifeClean International no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of kr3.00m in 2026. New forecast suggests the company will make a loss of kr4.00m in 2026.
Reported Earnings • Sep 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: kr21.0m (up 47% from 2Q 2023). Net loss: kr12.8m (loss widened 21% from 2Q 2023). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany.
Reported Earnings • May 08First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: kr16.0m (up 17% from 1Q 2023). Net loss: kr15.0m (loss widened 95% from 1Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.
New Risk • Apr 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr40m free cash flow). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Revenue is less than US$5m (kr53m revenue, or US$5.0m). Market cap is less than US$100m (€37.6m market cap, or US$40.9m).
Reported Earnings • Feb 21Full year 2023 earnings released: kr0.94 loss per share (vs kr0.83 loss in FY 2022)Full year 2023 results: kr0.94 loss per share (further deteriorated from kr0.83 loss in FY 2022). Revenue: kr53.7m (up 14% from FY 2022). Net loss: kr44.2m (loss widened 23% from FY 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr10.4m (up 17% from 3Q 2022). Net loss: kr11.9m (loss widened 44% from 3Q 2022). Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Aug 31Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: kr14.5m (down 2.6% from 2Q 2022). Net loss: kr10.6m (loss widened 46% from 2Q 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.
New Risk • Aug 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr5.0m net loss in 2 years). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr48m revenue, or US$4.5m). Market cap is less than US$100m (€30.0m market cap, or US$32.9m).
Reported Earnings • Feb 18Full year 2022 earnings released: kr0.83 loss per share (vs kr0.83 loss in FY 2021)Full year 2022 results: kr0.83 loss per share (further deteriorated from kr0.83 loss in FY 2021). Revenue: kr48.3m (down 18% from FY 2021). Net loss: kr36.1m (loss widened 1.0% from FY 2021). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 10LifeClean Develops Revolutionary Method for PFAS RemovalLifeClean International AB (publ) ("the Company") announces that the Company has developed an effective method for removing PFAS substances ("PFAS") from fire-fighting foam tanks.PFAS are environmentally and health-damaging substances previously used on a large scale as an ingredient in, e.g., fire-fighting foams. The phase-out of PFAS is ongoing and global, which opens up a significant market potential for the Company. Successful customer tests of LifeClean's method have already been conducted. The LifeClean group, under the leadership of Chairman and founder Ragnar Krefting, has researched, developed, and successfully tested a new method for PFAS removal from contaminated surfaces. The method is adapted for the best effect against PFAS and is part of a new assortment in LifeClean's product range. The new product assortment is based on the Company's patented chlorine dioxide formulation and also includes ingredients from the subsidiary Kempartner. Test results of the LifeClean method at Södertörn's firefighting association of five fire foam tanks have shown positive results where =99.97% of PFAS substances in the tanks have been detached according to an accredited third-party laboratory. In January 2023, the LifeClean-treated tanks would otherwise have been plugged and disposed of following current environmental and waste legislation. Now, this does not need to be done after decontaminating with the LifeClean method, which means a great economic saving of public funds. The same problem exists in the rest of the world, and the Company will, in a first step, process the Nordic market and, in a second step, the rest of the EU. An investigation is underway to see if it is possible to obtain regulatory exemptions for faster sales to countries where additional authorization is required. The company estimates that approx. 75,000 fire trucks in Europe are PFAS-contaminated and in need of decontamination. The estimated revenue per fire truck is approx. SEK 60,000 +/- 20,000, depending on tank size. PFAS are a group of chemicals with unique properties such as heat resistance and have, among other things, been an important ingredient in fire-fighting foams for firefighting at areas such as airports, ships, and defense facilities worldwide. PFAS are very resilient to degradation and are sometimes referred to as "forever chemicals". There is a high global consensus that PFAS should be phased out, even in fire-fighting foams where, among others, the carcinogenic and reproductively toxic substances PFOS and PFOA have been used.
Reported Earnings • Nov 06Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr9.10m (down 21% from 3Q 2021). Net loss: kr8.31m (loss narrowed 1.3% from 3Q 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.
Board Change • May 03No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Board member Jan Sjowall was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr0.78 loss per share (down from kr0.14 loss in FY 2020). Revenue: kr55.3m (up 69% from FY 2020). Net loss: kr32.8m (loss widened kr29.6m from FY 2020). Revenue missed analyst estimates by 52%.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved revenues, although losses increased and control over costs was weaker. Third quarter 2021 results: Revenue: kr12.1m (up 261% from 3Q 2020). Net loss: kr8.42m (loss widened 271% from 3Q 2020).
Reported Earnings • Aug 20Second quarter 2021 earnings released: kr0.15 loss per share (vs kr0.76 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: kr18.9m (down 3.2% from 2Q 2020). Net loss: kr6.36m (down 215% from profit in 2Q 2020).
Breakeven Date Change • Jul 27Forecast to breakeven in 2021The analyst covering LifeClean International expects the company to break even for the first time. New forecast suggests the company will make a profit of kr2.00m in 2021. Earnings growth of 101% is required to achieve expected profit on schedule.
Reported Earnings • May 06First quarter 2021 earnings releasedThe company reported a mediocre first quarter result with weaker earnings and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: kr12.0m (up 88% from 1Q 2020). Net loss: kr6.99m (down kr7.35m from profit in 1Q 2020).
Reported Earnings • Feb 21Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).
Is New 90 Day High Low • Jan 28New 90-day low: €0.93The company is down 11% from its price of €1.05 on 30 October 2020. The German market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.
